Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution MPC Q1 2026 Earnings Massive EPS Surprise of 1186 Drives Shares Higher CDZI Q1 2026 Earnings EPS Surprises to the Upside Despite No Reported Revenue CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment BCDA Q1 2026 Earnings EPS Misses Estimates as No Revenue Reported Stock Edges Higher BDTX Q1 2026 Earnings Narrowed Loss Surprises Yet Stock Declines 358